NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00517-6560-01 — Selenium injection solutionAI (149 hospitals, 48,299–48,947 samples)
• NDC 70069-0151-01 — Cisatracurium injection, 10 mg/mL intravenous solutionAI (263 hospitals, 48,162–48,936 samples)
• NDC 69374-0982-55 — Ketamine 10 mg/mL syringeAI (397 hospitals, 46,343–48,917 samples)
• NDC 00781-3153-95 — Cisatracurium injection, muscle relaxant for anesthesiaAI (224 hospitals, 48,139–48,895 samples)
• NDC 70121-1637-01 — Ephedrine sulfate injection, 50 mg/mLAI (155 hospitals, 48,137–48,875 samples)
• NDC 00409-1660-35 — Dexmedetomidine IV infusion in salineAI (126 hospitals, 48,137–48,875 samples)
• NDC 63323-0421-01 — Dexmedetomidine sedation medication, IV solutionAI (97 hospitals, 48,137–48,875 samples)
• NDC 17478-0403-03 — Fluorescein eye test stripsAI (220 hospitals, 48,165–48,840 samples)
• NDC 63323-0724-01 — REMIFENTANIL 2 MG INTRAVENOUS SOLUTIONAI (200 hospitals, 48,172–48,838 samples)
• NDC 00517-6560-05 — Selenious acid injection (intravenous)AI (205 hospitals, 48,177–48,825 samples)
• NDC 00641-6057-25 — Midazolam injection, 2 mg per 2 mLAI (716 hospitals, 41,355–48,807 samples)
• NDC 70121-1605-01 — ISOPROTERENOL 0.2 MG/ML INJECTION SOLUTIONAI (88 hospitals, 48,127–48,775 samples)
• NDC 42023-0120-06 — Liothyronine injection (IV thyroid hormone solution)AI (101 hospitals, 48,127–48,775 samples)
• NDC 00264-9341-55 — Amino acid intravenous solutionAI (239 hospitals, 48,127–48,775 samples)
• NDC 42023-0120-01 — Liothyronine (thyroid hormone) injectionAI (74 hospitals, 48,127–48,775 samples)
• NDC 70121-1604-07 — Isoproterenol injection 0.2 mg/mL solutionAI (62 hospitals, 48,127–48,775 samples)
• NDC 70121-1604-01 — Isoproterenol injectionAI (59 hospitals, 48,127–48,775 samples)
• NDC 00641-6057-01 — Midazolam 1 mg/mL injectionAI (554 hospitals, 42,396–48,687 samples)
• NDC 00143-9594-25 — Lidocaine 2% injection solutionAI (550 hospitals, 38,911–48,649 samples)
• NDC 23155-0600-41 — Midazolam injection, 2 mg per 2 mLAI (642 hospitals, 42,718–48,631 samples)
• NDC 00641-6247-25 — Fentanyl citrate injection, 50 mcg per mLAI (370 hospitals, 33,015–48,387 samples)
• NDC 64380-0769-21 — Polyethylene glycol electrolyte solution bowel prepAI (253 hospitals, 48,211–48,346 samples)
• NDC 00019-1332-11 — Ioversol contrast dye for IV imaging, 300 mg iodine/mLAI (54 hospitals, 48,271–48,298 samples)
• NDC 00270-1315-47 — Iopamidol 300 mg/mL contrast injectionAI (58 hospitals, 48,271–48,298 samples)
• NDC 60793-0217-22 — Topical bovine thrombin spray kitAI (395 hospitals, 47,617–48,292 samples)
• NDC 55566-2800-00 — Dinoprostone vaginal insertAI (225 hospitals, 47,592–48,231 samples)
• NDC 00009-0283-01 — Absorbable gelatin film implantAI (120 hospitals, 47,592–48,231 samples)
• NDC 00409-1587-50 — Bupivacaine 0.25% injectionAI (255 hospitals, 46,709–48,158 samples)
• NDC 00409-4888-01 — Sodium chloride 0.9% injection, preservative-freeAI (254 hospitals, 46,127–48,152 samples)
• NDC 00169-4132-12 — Semaglutide injection pen (0.25 mg or 0.5 mg)AI (44 hospitals, 47,582–48,131 samples)
• NDC 00409-4276-16 — Lidocaine 1% local numbing injectionAI (504 hospitals, 43,169–48,083 samples)
• NDC 55150-0471-10 — Vancomycin hydrochloride 1.25 g IV powderAI (262 hospitals, 47,426–48,011 samples)
• NDC 49502-0102-01 — Epinephrine auto-injector, 0.3 mg doseAI (405 hospitals, 45,831–47,937 samples)
• NDC 63323-0208-05 — Lidocaine injection, 100 mg per 5 mLAI (832 hospitals, 40,534–47,905 samples)
• NDC 63323-0492-16 — Lidocaine 1% numbing injectionAI (202 hospitals, 44,843–47,858 samples)
• NDC 00409-9094-17 — Fentanyl citrate injection, preservative-free (500 mcg/10 mL)AI (248 hospitals, 36,774–47,853 samples)
• NDC 00168-0004-15 — Triamcinolone acetonide 0.1% creamAI (482 hospitals, 46,563–47,841 samples)
• NDC 00270-1315-41 — Iopamidol contrast dye for IV imaging, 300 strengthAI (97 hospitals, 47,320–47,824 samples)
• NDC 49502-0101-01 — Epinephrine auto-injector 0.15 mgAI (278 hospitals, 45,719–47,807 samples)
• NDC 68462-0755-25 — Ketorolac tromethamine 15 mg/mL injectionAI (195 hospitals, 45,757–47,512 samples)
• NDC 76045-0009-01 — Hydromorphone injection syringeAI (527 hospitals, 33,723–47,511 samples)
• NDC 25021-0777-02 — Ondansetron 4 mg/2 mL injectionAI (296 hospitals, 44,693–47,375 samples)
• NDC 00168-0204-37 — lidocaine 5 % topical ointmentAI (486 hospitals, 46,077–47,301 samples)
• NDC 63323-0623-61 — Sodium chloride 0.9% saline bag, 100 mLAI (178 hospitals, 43,796–47,234 samples)
• NDC 63323-0806-14 — Fentanyl injection, 50 mcg per mLAI (287 hospitals, 38,695–47,110 samples)
• NDC 00115-1694-49 — Epinephrine auto-injector 0.3 mgAI (363 hospitals, 45,901–47,071 samples)
• NDC 63323-0495-07 — Lidocaine injection (Xylocaine, 2%)AI (791 hospitals, 38,910–46,983 samples)
• NDC 00407-1414-08 — Iohexol 350 oral contrast solutionAI (145 hospitals, 45,420–46,869 samples)
• NDC 72485-0107-01 — Tranexamic acid injection, 1,000 mg IVAI (128 hospitals, 44,947–46,855 samples)
• NDC 00409-3796-19 — Ketorolac injection 60 mg/2 mLAI (266 hospitals, 45,075–46,830 samples)